Bladder Cancer Chemopreventive Agents: Current Knowledge and Concepts

Mini Rev Med Chem. 2018;18(13):1143-1150. doi: 10.2174/1389557516666160315114132.

Abstract

Bladder cancer is the most prevalent malignancy of the urinary tract and is associated with significant morbidity and mortality. Preventative efforts to reduce the medical and financial burdens of bladder cancer are highly desirable. However, the utilization of natural and pharmaceutical products for the prevention and treatment of bladder cancer remains largely controversial. Herein, we review the current body of evidence surrounding a number of natural dietary substances and their roles in chemoprevention of bladder cancer. Possible chemopreventative properties of several pharmaceutical agents are also reviewed. Overall, the current body of evidence is insufficient to establish a clear link between these proposed chemopreventive agents and risk of bladder cancer.

Keywords: Bladder cancer; Chemoprevention; DNA; Vitamin D; green tea; heterogeneous disease..

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antineoplastic Agents / therapeutic use*
  • Chemoprevention
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Metformin / therapeutic use
  • Polyphenols / chemistry
  • Polyphenols / therapeutic use
  • Selenium Compounds / chemistry
  • Selenium Compounds / therapeutic use
  • Urinary Bladder Neoplasms / pathology
  • Urinary Bladder Neoplasms / prevention & control*
  • Vitamins / therapeutic use

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antineoplastic Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Polyphenols
  • Selenium Compounds
  • Vitamins
  • Metformin